From: Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients
Control group | PE group | P value | ||||
---|---|---|---|---|---|---|
CD4+ /CD3+T cell (%) | 47.52 ± 10.58 | 52.49 ± 6.91 | 0.0604 | |||
CD8+ /CD3+T cell (%) | 34.87 ± 8.41 | 33.30 ± 7.74 | 0.5044 | |||
CD25+CD127low/CD4+ T cell (%) | 7.48 ± 1.71 | 6.43 ± 1.77 | 0.0420 |